Description: HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.
Home Page: www.haemato.ag
Lilienthalstrasse 5c
Schönefeld,
12529
Germany
Phone:
49 30 897 30 86 70
Officers
| Name | Title |
|---|---|
| Mr. Patrick Brenske | MD & Member of Management Board |
| Mr. Attila Strauss | Managing Director & Member of Management Board |
Exchange: F
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 105.8824 |
| Price-to-Book MRQ: | 0.6429 |
| Price-to-Sales TTM: | 0.3607 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 76 |